An additional 0.5 percent were re-determined with AF , making a total of 1 1.5 per cent identified with unknown AF. Importantly it identified all cases of unknown AF in the SEARCH-AF study previously. Many people with previously unknown AF in SEARCH did not have symptoms and acquired a normal resting heartrate of 77 beats each and every minute, yet almost all were at increased threat of eligible and stroke for stroke prevention therapy with oral anticoagulant medication. In the people who have a known background of AF , the experts identified cure gap as only 66 percent of those qualified to receive stroke prevention medication were being prescribed this medication.All analyses were performed separately by the trial statisticians in britain and Australia and were cross-checked. A two-sided P value of significantly less than 0.05 was considered to indicate statistical significance without adjustment for multiple comparisons. All analyses were performed about the intention-to-treat theory at randomization, of deviations from the protocol regardless. Outcomes were summarized with the use of counts and %ages for categorical variables and of means and regular deviations for normally distributed constant variables. The magnitude and direction of treatment results had been expressed as relative dangers, with 95 percent confidence intervals adjusted for country.